Page last updated: 2024-09-03
tetrahydrocurcumin and Granulocytic Leukemia
tetrahydrocurcumin has been researched along with Granulocytic Leukemia in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Badmaev, V; Ho, CT; Lai, CS; Nagabhushanam, K; Pan, MH; Wu, JC | 1 |
Other Studies
1 other study(ies) available for tetrahydrocurcumin and Granulocytic Leukemia
Article | Year |
---|---|
Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells.
Topics: Adenine; Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Proliferation; Curcumin; Down-Regulation; HL-60 Cells; Humans; Leukemia, Myeloid; MAP Kinase Signaling System; Membrane Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2011 |